Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01452347
Show Display Options
Rank Status Study
1 Terminated
Has Results
Dabigatran Etexilate in Patients With Mechanical Heart Valves
Condition: Heart Valve Diseases
Interventions: Drug: warfarin 1mg;   Drug: dabigatran etexilate intermediate dose;   Drug: dabigatran etexilate low dose;   Drug: warfarin 5mg;   Drug: dabigatran etexilate high dose;   Drug: warfarin 3mg

Indicates status has not been verified in more than two years